MARCELA V. MAUS, M.D., PH.D.
Professor of Medicine, Harvard Medical School
Director, Cellular Immunotherapy; Paula J. O’Keeffe Endowed Chair in Cancer Research; Investigator, Krantz Family Center for Cancer Research; and Attending Physician, Hematopoietic Cell Transplant & Cell Therapy Program, Massachusetts General Hospital
Associate Director, Gene and Cell Therapy Institute, Mass General Brigham
Associate Member, Broad Institute of MIT and Harvard

MARCELA V. MAUS is a professor of medicine at Harvard Medical School. At Massachusetts General Hospital (MGH), she is the director of cellular immunotherapy, the Paula J. O’Keeffe endowed chair in cancer research, an investigator at the Krantz Family Center for Cancer Research, and an attending physician in the Hematopoietic Cell Transplant & Cell Therapy Program. She is also an associate member of the Broad Institute of MIT and Harvard.

Maus is internationally known for her work as a translational physician-scientist in the field of immunology, particularly as it relates to T cell-based immunotherapies and cellular therapies in the treatment of cancer. Her laboratory focuses on the biology of human T cell activation, costimulation, and memory, and on the application of human T cell therapies to human disease, including forward and reverse translation of engineered T cell therapies in early-phase clinical trials. She has authored more than 100 peer-reviewed papers and holds multiple NIH R01 grants and Investigational New Drug Applications. Maus completed undergraduate studies at MIT and holds an M.D. and Ph.D. from the University of Pennsylvania. She trained in internal medicine at the University of Pennsylvania and in hematology and medical oncology at Memorial Sloan Kettering Cancer Center. She also serves on several scientific and clinical advisory boards for the biotechnology industry as well as external academic medical centers.